Well, ABT withdrew Meridia "voluntarily" at the request of FDA. I am not sure how "voluntary" ABT actually did. FDA might not have forcefully asked if there were no advisory panel.
As of taxpayer money, this case is the least I am worried about. Tons of big waste in other areas. I'd say it needs to cut other wastes, give FDA more money to speed up both approval and enforcement.
Market Data 
Markets 
AI
